A novel coronavirus (2019-nCoV) has raised world concern since it emerged in Wuhan Hubei China in December, 2019. The infection may result into severe pneumonia with clusters illness onsets. Its impacts on public health make it paramount to clarify the clinical features with other pneumonias.
Background
In the end of 2019, a novel coronavirus (2019-nCoV) emerged in Wuhan Hubei province, China [1] . Reports showed that the 2019-nCoV infection caused clusters onset similar to severe acute respiratory syndrome coronavirus (SARS) [1, 2] . Previous study has shown that coronaviruses can cause respiratory and intestinal infections in animals and humans [3] .
Generally, coronaviruses were not considered to be highly pathogenic to humans until the outbreak of severe acute respiratory syndrome (SARS) in 2002 and 2003 in Guangdong， China [4, 5] . Another highly pathogenic coronavirus, Middle East respiratory syndrome (MERS) coronavirus emerged in Middle Eastern countries in 2012 [6] . 2019-nCoV is one more highly pathogenic coronavirus to human in history.
The virus has raised world concern because of its high transmission capability as well as high mobility and mortality [2, [7] [8] [9] . As of 14 th Feb 2020, more than 60000 cases with over 8000 severe patients infected with the virus have been reported, and more than 1500 patients died.
In addition to China, the patients have been detected in 25 countries globally. Early reports showed that almost all of confirmed patients have evidence of pneumonia [7, 9] . However, pneumonias are very common during a time of year when respiratory illnesses caused by other pathogens infection are highly prevalent [10, 11] . So it is a very hard time for public health as well as doctors in this outbreak.
In this study, we investigated the clinical features of 19 confirmed 2019-nCoV pneumonia (NCOVID-19) cases and 15 2019-nCoV negative confirmed pneumonia patients (NCOVID- 19 ) with a history of travel to Hubei or exposure before illness to NCOVID-19 confirmed patients to describe the potential differences of clinical features between the two diseases.
Materials and methods

Patients
For comparative study, we recruited 19 NCOVID-19 patients and 15 NON-NCOVID-19 patients from Jan 23 to Feb 5, 2020, at the Second Affiliated Hospital of Anhui Medical University and Suzhou Municipal Hospital in Anhui province, China. NCOVID-19 or NON-NCOVID-19 cases were confirmed to be infected with or without 2019-nCoV by real-time RT-PCR. NCOVID-19 was defined to be 2019-nCoV negative by PCR detection. For NON-NCOVID-19 confirmation, we collected a throat swab or sputum sampling every other day.
The patient was confirmed as NON-NCOVID-19 if three consecutive real-time PCR tests were negative during first 7 days of admission.
Real-time PCR detection for identification of pathogens
According to the surveillance scheme of pneumonia cases with 2019-nCoV infection and the guideline of laboratory detection for NCOVID- 19[12] , local Centres for Disease Control and Prevention collected throat swabs or/and sputa from suspected patients, then shipped them to designated authoritative laboratories to detect the pathogen. RNA was extracted from those collected samples. Specific real-time reverse transcription polymerase chain reaction (rRT-PCR) assays were performed to identify influenza A virus (H1N1, H3N2, H5N1, H7N9), influenza B virus, respiratory syncytial virus, parainfluenza virus, adenovirus, SARS coronavirus (SARS-CoV), and MERS coronavirus (MERS-CoV) using commercial kits or designed nCoV rRT-PCR kit by China CDC.
Data collection
We reviewed clinical charts, nursing records, laboratory findings, and chest x-rays for all NCOVID-19 and NCOVID-19 patients. The admission data of these patients were from Jan 23 to Feb 5, 2020. Epidemiological, clinical, laboratory, and radiological characteristics data were obtained with standardized data collection forms from electronic medical records. Investigators interviewed each patient and their relatives, where necessary, to determine exposure or close contact histories during the 2 weeks before the illness onset. To ascertain the epidemiological and symptom data, which were not available from electronic medical records, the researchers also directly communicated with patients or their families to ascertain epidemiological or symptom data. If data were missing from the records or clarification was needed, we obtained data by direct communicating with attending doctors and other healthcare providers. All data were checked by two physicians.
Statistical analysis
The quantitative blood laboratory tests were compared by Mann-Whitney U test. The categorical variables were expressed as number (%) and compared by Fisher's exact test.
Differences were considered significant at p< 0.05 with a two-tailed test. All analysis was performed using Instat software (Vision 5.0, GraphPad prism). Serological assays showed mycoplasma against IgM positive in two patients.
Results
Demographic characteristics of cases
Illness onset features of patients
To decrease the possible affect on laboratory results, we selected those patients with similar duration between nCoV and non-CoV in this study. The median duration, respectively, was 5 (IQR: 3~9) and 4 (IQR:2~7) days from onset to admission in NCOVID-19 and NON-NCOVID-19 patients. It was no statistical difference between them. On admission, the most common symptoms at onset of illness were fever and cough in both NCOVID- 19 2 ). In comparison, no significant differences were observed between NCOVID-19 and NON-NCOVID-19 patients on these onsets.
The features of CT images
On admission, of the 19 NCOVID-19 patients, 15 (78.95%) had bilateral involvement (table   2) . Similar with previous reports [13] , the typical feature is multiple lobular ground-glass opacity ( patients. In addition, sequential CT images from same patient suggested that the inflammation was rapid infiltration in lobes of NCOVID-19 patients ( Figure A 
In comparison, of 15 NON-NCOVID-19 patients, only 4 (26.7%) had bilateral involvement (table 2). The typical features of NON-NCOVID-19 were patchy shadow or density increasing shadow ( Figure H ), except for one (6.67%) had multiple patchy and mottling shadows with partial ground-glass opacity ( Figure I ).
Laboratory abnormalities of the patients
On admission, except one NCOVID-19 patient, WBC numberings of the investigated patients were in normal range whereas most lymphocytes were decreased in NCOVID- 19 Table 3) . One of NCOVID-19 patient with abnormal LDH also showed abnormal CK (365 U/L) while there was no significant difference between CK levels of NCOVID-19 and NCOVID-19 patients. In addition, most of both NCOVID-19 and NON-NCOVID-19 patients presented increased levels of CRP and IL-6 whereas no significant difference was observed between the two grouped patients.
Creatinine levels of all patients were normal (data not shown).
Outcome and treatments
By the end of 14th Feb 2020, no patient need be admitted to Intensive Care Unit (ICU) and administered with mechanical ventilation in these investigated NCOVID-19 and NON-NCOVID-19 patients. Except for two NCOVID-19 patients had a transient decreasing of pulse oxygen saturation (SpO2) (92-93%) on admission, SpO2 of others kept at 95%-99%.
All of NCOVID-19 patients were treated with antiviral drug lopinavir and ritonavir tablets and symptomatic supports while NON-NCOVID-19 patients were treated with antibiotics (moxifloxacin) and other symptomatic supports. Besides drug treatments, a large proportion of the ingredients were psychological counseling for these NCOVID-19 patients because of the panic and anxiety to the illness.
Discussion
The 2019-nCoV which caused severe illness has impacted multiple countries in the world, and sustained human-to-human transmission making it a world concerning and serious public health threat [14] . So far, it is unclear when it will be end actually. However, the caused symptoms of the virus are similar to those of influenza (e.g., fever, cough, or sore throat), and the outbreak is occurring during a time of year when respiratory illnesses from influenza, respiratory syncytial virus, and other respiratory viruses are highly prevalent. It is a very important for clinics to indentify the infected patients.
We report here a comparative analysis on 19 pneumonia patients with laboratory-confirmed 2019-nCoV infection and 15 pneumonia patients without 2019-nCoV infection. All patients had the exposure history to confirmed 2019-nCoV patient or traveled back from Hubei before illness. The epidemiology data showed the two group patients presented onsets after mean one week around. Similar symptoms were presented by both group patients. Fever and cough were the most common symptoms. These symptoms are also common in other acute respiratory infections such as influenza, respiratory syncytial virus and other respiratory viruses, which may be associated with the difficult control of this epidemic.
Early Classification of patients is necessary to prevent and control these epidemics when emergency management have to be conducted in some outbreaks like SARS and 2019-nCOV [15, 16] . Previous suggested that CT scan was a useful tool to screen the suspected cases of 2019-nCOV infection [13] . In this study, our data also showed that CT images had remarkably significant difference between NCOVID-19 and NON-NCOVID-19 patients.
Most NCOVID-19 patients but NON-NCOVID-19 had bilateral pneumonia with the feature of a multiple mottling and ground-glass opacity in CT images. In addition, somewhat like severe influenza (e.g. H7N9, H1N1pdm 09) [17, 18] , inflammation spread quickly in lungs of NCOVID-19 patients. CT scan may be a reliable test for screening NCOVID-19 or NCOVID-19 patients, will compact quick classification of suspected cases or common patients.
In terms of laboratory tests, the absolute value of lymphocytes in most NCOVID-19 and NON-NCOVID-19 patients was reduced. This result suggests that 2019-nCoV infection has similar feature with many other respiratory virus infections, triggered strong innate inflammatory immune response, and caused depletion of lymphocytes after infection [19] [20] [21] [22] .
Inflammation is a time-depend process, usually starting locally, and is recognized centrally later via blood born mediators [23] . Previous studies suggested that excessive immune response played an important role on pathogenesis of severe influenza or SARS [24] . And IL-6 and CRP may link to the excessive immune response [25, 26] . In this study, our results also showed abnormally increased CRP and IL-6 in most of both NCOVID-19 and NON-NCOVID-19 patients. In our results, the ratio mean of neutrophils is slightly higher in NCOVID-19 than in NON-NCOVID-19 although no statistic difference between them. That might be related to no severe cases involved in this study because numbers of neutrophils was much higher in severe NCOVD-19 than relatively mild NCOVID-19 in Early report [2] .
Previous studies have shown that excessive neutrophils contributed to acute lung damage, and are associated with severe disease and fatality in patients with influenza infection [27, 28] . Hence, possibly, excessive immune of host may be associated with the pathogenesis of NCOVID-19 besides virus-specific factors.
Previous reports showed that a proportion of NCOVID-19 patients had differing degrees of liver function abnormality [2, 7] . Our data showed that the levels of liver function associated markers (ALT, AST and γ-GT) were significantly higher in NCOVID-19 patients than in NON-NCOVID-19 patients, and a proportion of NCOVID-19 patients (AST, 26.67%; ALT 27.78%; γ-GT, 44.44%) but NON-NCOVID-19 patients presented abnormal levels of these markers, suggested that acute liver damage was more frequent in NCOVID-19 patients than NON-NCOVID-19 patients. This was also observed in SARS or severe influenza (e.g. H7N9) patients [17, 29] . In addition, LDH showed abnormal level in a proportion of NCOVID-19 patients (31.58%) but in NCOVID-19 patients. And available data showed that most of NCOVID-19 patients (75%) but NCOVID-19 patients (20%) had an abnormal α-HBDH. The results suggested that 2019-nCoV infected patient may result into multiple tissues or organs damage besides liver injury.
As for treatment, all NCOVID-19 patients were diagnosed and treated in out of Wuhan places in this study. And all NCOVID-19 patients in this study didn't have severe complication like ARDS or multiple organ failure which was reported in Wuhan patients or SARS patients during the admission [2, 7, 29, 30] . However, as for a novel disease, common people have more panic and anxiety on it than other diseases. Psychological counseling should be involved in treatment ingredients.
There are several limitations in this study. Firstly, the sample size was very small. And some laboratory tests weren't conducted in some patients because the NCOVID-19 patients were from two hospitals. Secondly, there was lack of severe infection, to compare findings with severe infection with mild infection. Thirdly, there was lack of pediatric population. 
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